Updated Analysis of Phase II Study of HA-Irinotecan, a CD44-Targeting Formulation of Hyaluronic Acid and Irinotecan, in Small Cell Lung Cancer

被引：3

作者：

Alamgeer, Muhammad ^{[1
]}

Briggs, Peter ^{[1
]}

Markman, Ben ^{[1
]}

Midolo, Peter ^{[1
]}

Watkins, Neil ^{[2
]}

Kumar, Beena ^{[3
]}

Ganju, Vinod ^{[1
]}

机构：

[1] Monash Canc Ctr, Med Oncol, East Bentleigh, Australia

[2] Garvan Inst Med Res, Kinghorn Canc Ctr, Darlinghurst, NSW, Australia

[3] Monash Med Ctr, Anat Pathol, Clayton, Vic, Australia

来源：

关键词：

Hyaluronic acid; small cell lung cancer; CD44; irinotecan;

D O I：

10.1016/j.jtho.2016.11.915

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.07-004

引用

页码：S697 / S698

页数：2